In his role as CSO at BioAgilytix Dr. Briscoe is responsible for driving short long-term scientific strategy. He works with pharmaceutical companies around the world to help them better plan for and execute the bioanalytical and biomarker aspects of their clinical trials. He leverages his nearly 25 years of experience as a Bioanalytical Scientist and Executive to bring practical solutions to the ever-increasing complexity of clinical trials. He is a recognized global expert and thought leader in areas such as biomarker analysis, LC/MS/MS bioanalysis and analytical instrument qualification. He has been a frequent speaker at various global and regional conferences on these topics. Dr. Briscoe holds a PhD from the University of Nebraska where he studied protein binding interactions using immunoaffinity chromatography. He also has a master’s degree from the University of Michigan and bachelor’s degree from Alma College in Michigan.
“Just because something works, doesn't mean it can't be improved.”